The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Renal Biomarker Market Research Report 2024
Synopsis
The global Renal Biomarker market was valued at US$ 975.6 million in 2023 and is anticipated to reach US$ 1321.2 million by 2030, witnessing a CAGR of 4.0% during the forecast period 2024-2030.
North American market for Renal Biomarker is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Renal Biomarker is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Renal Biomarker in Hospitals is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Renal Biomarker include Beckman Coulter (Danaher), Thermo Fisher Scientific, Abbott Laboratories, BioPorto Diagnostics, Astute Medical and Randox Laboratories, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Renal Biomarker, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Renal Biomarker.
Report Scope
The Renal Biomarker market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Renal Biomarker market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Renal Biomarker companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Beckman Coulter (Danaher)
Thermo Fisher Scientific
Abbott Laboratories
BioPorto Diagnostics
Astute Medical
Randox Laboratories
Segment by Type
Functional Biomarker
Up-Regulated Proteins
Others
Segment by Application
Hospitals
Diagnostic Labs
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Renal Biomarker companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global Renal Biomarker market was valued at US$ 975.6 million in 2023 and is anticipated to reach US$ 1321.2 million by 2030, witnessing a CAGR of 4.0% during the forecast period 2024-2030.
North American market for Renal Biomarker is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Renal Biomarker is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Renal Biomarker in Hospitals is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Renal Biomarker include Beckman Coulter (Danaher), Thermo Fisher Scientific, Abbott Laboratories, BioPorto Diagnostics, Astute Medical and Randox Laboratories, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Renal Biomarker, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Renal Biomarker.
Report Scope
The Renal Biomarker market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Renal Biomarker market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Renal Biomarker companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Beckman Coulter (Danaher)
Thermo Fisher Scientific
Abbott Laboratories
BioPorto Diagnostics
Astute Medical
Randox Laboratories
Segment by Type
Functional Biomarker
Up-Regulated Proteins
Others
Segment by Application
Hospitals
Diagnostic Labs
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Renal Biomarker companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Renal Biomarker Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Functional Biomarker
1.2.3 Up-Regulated Proteins
1.2.4 Others
1.3 Market by Application
1.3.1 Global Renal Biomarker Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Diagnostic Labs
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Renal Biomarker Market Perspective (2019-2030)
2.2 Renal Biomarker Growth Trends by Region
2.2.1 Global Renal Biomarker Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Renal Biomarker Historic Market Size by Region (2019-2024)
2.2.3 Renal Biomarker Forecasted Market Size by Region (2025-2030)
2.3 Renal Biomarker Market Dynamics
2.3.1 Renal Biomarker Industry Trends
2.3.2 Renal Biomarker Market Drivers
2.3.3 Renal Biomarker Market Challenges
2.3.4 Renal Biomarker Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Renal Biomarker Players by Revenue
3.1.1 Global Top Renal Biomarker Players by Revenue (2019-2024)
3.1.2 Global Renal Biomarker Revenue Market Share by Players (2019-2024)
3.2 Global Renal Biomarker Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Renal Biomarker Revenue
3.4 Global Renal Biomarker Market Concentration Ratio
3.4.1 Global Renal Biomarker Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Renal Biomarker Revenue in 2023
3.5 Renal Biomarker Key Players Head office and Area Served
3.6 Key Players Renal Biomarker Product Solution and Service
3.7 Date of Enter into Renal Biomarker Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Renal Biomarker Breakdown Data by Type
4.1 Global Renal Biomarker Historic Market Size by Type (2019-2024)
4.2 Global Renal Biomarker Forecasted Market Size by Type (2025-2030)
5 Renal Biomarker Breakdown Data by Application
5.1 Global Renal Biomarker Historic Market Size by Application (2019-2024)
5.2 Global Renal Biomarker Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Renal Biomarker Market Size (2019-2030)
6.2 North America Renal Biomarker Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Renal Biomarker Market Size by Country (2019-2024)
6.4 North America Renal Biomarker Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Renal Biomarker Market Size (2019-2030)
7.2 Europe Renal Biomarker Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Renal Biomarker Market Size by Country (2019-2024)
7.4 Europe Renal Biomarker Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Renal Biomarker Market Size (2019-2030)
8.2 Asia-Pacific Renal Biomarker Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Renal Biomarker Market Size by Region (2019-2024)
8.4 Asia-Pacific Renal Biomarker Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Renal Biomarker Market Size (2019-2030)
9.2 Latin America Renal Biomarker Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Renal Biomarker Market Size by Country (2019-2024)
9.4 Latin America Renal Biomarker Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Renal Biomarker Market Size (2019-2030)
10.2 Middle East & Africa Renal Biomarker Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Renal Biomarker Market Size by Country (2019-2024)
10.4 Middle East & Africa Renal Biomarker Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Beckman Coulter (Danaher)
11.1.1 Beckman Coulter (Danaher) Company Detail
11.1.2 Beckman Coulter (Danaher) Business Overview
11.1.3 Beckman Coulter (Danaher) Renal Biomarker Introduction
11.1.4 Beckman Coulter (Danaher) Revenue in Renal Biomarker Business (2019-2024)
11.1.5 Beckman Coulter (Danaher) Recent Development
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Detail
11.2.2 Thermo Fisher Scientific Business Overview
11.2.3 Thermo Fisher Scientific Renal Biomarker Introduction
11.2.4 Thermo Fisher Scientific Revenue in Renal Biomarker Business (2019-2024)
11.2.5 Thermo Fisher Scientific Recent Development
11.3 Abbott Laboratories
11.3.1 Abbott Laboratories Company Detail
11.3.2 Abbott Laboratories Business Overview
11.3.3 Abbott Laboratories Renal Biomarker Introduction
11.3.4 Abbott Laboratories Revenue in Renal Biomarker Business (2019-2024)
11.3.5 Abbott Laboratories Recent Development
11.4 BioPorto Diagnostics
11.4.1 BioPorto Diagnostics Company Detail
11.4.2 BioPorto Diagnostics Business Overview
11.4.3 BioPorto Diagnostics Renal Biomarker Introduction
11.4.4 BioPorto Diagnostics Revenue in Renal Biomarker Business (2019-2024)
11.4.5 BioPorto Diagnostics Recent Development
11.5 Astute Medical
11.5.1 Astute Medical Company Detail
11.5.2 Astute Medical Business Overview
11.5.3 Astute Medical Renal Biomarker Introduction
11.5.4 Astute Medical Revenue in Renal Biomarker Business (2019-2024)
11.5.5 Astute Medical Recent Development
11.6 Randox Laboratories
11.6.1 Randox Laboratories Company Detail
11.6.2 Randox Laboratories Business Overview
11.6.3 Randox Laboratories Renal Biomarker Introduction
11.6.4 Randox Laboratories Revenue in Renal Biomarker Business (2019-2024)
11.6.5 Randox Laboratories Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
